Stockreport

UK cost watchdog recommends Novartis' blindness therapy Luxturna [Reuters (UK)]

SPARK THERAPEUTICS INC  (ONCE) 
Last spark therapeutics inc earnings: 11/7 04:35 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sparktx.com/investor-overview
PDF UK cost watchdog recommends Novartis' blindness therapy Luxturna - Reuters 2 Min Read (Reuters) - Novartis AG’s ( NOVN.S ) gene therapy for blindness, Luxturna, is rec [Read more]